C
DAWN

Covestor’s Day One Biopharmaceuticals DAWN Stock Holding History

Covestor’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
12
-224
-95% -$3.16K ﹤0.01% 2350
2025
Q4 		$2K Buy
236
+181
+329% +$1.51K ﹤0.01% 1903
2025
Q3 		$0 Buy
55
+43
+358% +$296 ﹤0.01% 2360
2025
Q2 		$0 Sell
12
-17
-59% -$117 ﹤0.01% 2299
2025
Q1 		$0 Buy
29
+22
+314% +$237 ﹤0.01% 2311
2024
Q4 		$0 Hold
7
– – ﹤0.01% 2316
2024
Q3 		$0 Hold
7
– – ﹤0.01% 2303
2024
Q2 		$0 Hold
7
– – ﹤0.01% 2317
2024
Q1 		$0 Sell
7
-1
-13% -$15 ﹤0.01% 2317
2023
Q4 		$0 Sell
8
-1
-11% -$12 ﹤0.01% 2230
2023
Q3 		$0 Sell
9
-1
-10% -$13 ﹤0.01% 2207
2023
Q2 		$0 Buy
10
+4
+67% +$52 ﹤0.01% 2218
2023
Q1 		$0 Hold
6
– – ﹤0.01% 2116
2022
Q4 		$0 Hold
6
– – ﹤0.01% 2150
2022
Q3 		$0 Buy
+6
New +$128 ﹤0.01% 2093

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Covestor's DAWN Position: Q1 2026 in Review

Covestor reduced its Day One Biopharmaceuticals (DAWN) stake by 95% in Q1 2026, selling an estimated $3.16K and leaving 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2350.

Covestor first reported a position in DAWN in Q3 2022 and has held it in 15 quarters since. The position peaked at $2K in Q4 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Covestor held 12 shares of Day One Biopharmaceuticals worth $0 as of Q1 2026.
  • Covestor sold 224 Day One Biopharmaceuticals shares in Q1 2026, an estimated $3.16K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2350 holding.
  • Covestor first reported a position in Day One Biopharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • Covestor's Day One Biopharmaceuticals position peaked at $2K in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.